GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Primary Health Properties PHP.L · GBp

Real Estate · LSE · 🇬🇧 United Kingdom

Compare

97.30p

-0.36%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in GBP, from our data supplier.

FY2025

Revenue

£259.0m

FY2016FY2025

Net income

£119.0m

FY2016FY2025

Free cash flow

—

FY2016FY2025

Shareholders' equity

£2.55bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue£259.0m£181.7m£169.8m£85.7m£222.7m£128.6m−£46.5m£79.6m£72.5m£67.4m
Gross profit£232.0m£155.7m£151.0m£85.7m£222.7m£128.6m−£46.5m£76.4m£71.3m£66.6m
Research and development——£0£0£1£1£1£1£1£1
Operating income£202.0m£93.8m£84.3m£97.4m£219.5m£112.4m−£31.7m£93.1m£91.9m£59.3m
Net income£119.0m£41.4m£27.3m£56.3m£140.1m£112.0m−£71.3m£74.3m£91.9m£43.7m
Diluted earnings per share0.050.030.020.040.100.08-0.060.100.140.06

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets£6.04bn£2.79bn£2.83bn£2.86bn£2.85bn£2.70bn£2.57bn£1.51bn£1.37bn£1.23bn
Cash and short-term investments£20.0m£3.5m£13.7m£29.1m£33.4m£103.6m£143.1m£5.9m£4.1m£5.1m
Total liabilities£3.48bn£1.42bn£1.40bn£1.38bn£1.35bn£1.28bn£1.34bn£726.0m£785.6m£729.4m
Debt£3.31bn£1.34bn£1.33bn£1.30bn£1.28bn£1.22bn£1.27bn£676.1m£730.4m£668.4m
Shareholders' equity£2.55bn£1.38bn£1.42bn£1.48bn£1.50bn£1.41bn£1.23bn£788.0m£586.8m£499.2m
Shares outstanding2,606m1,337m1,337m1,337m1,440m1,398m1,190m740m648m683m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations£104.0m£135.2m£133.6m£79.3m£100.2m£79.2m£57.6m£68.5m£60.1m£56.8m
Capital spending−£104.0m———−£146.4m—−£55.8m—−£75.4m—
Free cash flow—£135.2m£133.6m£79.3m−£46.2m£79.2m£1.8m£68.5m−£15.3m£56.8m
Dividends paid−£144.0m−£92.1m−£89.5m−£81.6m−£74.4m−£69.1m−£54.4m−£34.7m−£29.8m−£24.7m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Mar 2023
Revenue£197.0m£169.3m£89.7m£89.8m£91.9m£85.9m£83.9m£42.0m
Gross profit£176.0m£152.7m£78.5m£78.0m£77.3m£75.4m£75.6m£38.0m
Operating income£163.0m£135.5m£67.6m£67.7m£30.5m£9.0m£75.3m£23.6m
Net income£99.0m£59.6m£59.4m£37.8m£3.6m−£12.2m£39.5m£19.8m
Diluted earnings per share0.040.020.020.030.00-0.010.030.01
Cash from operations£89.0m£53.0m£50.0m£46.0m£42.0m£43.0m£43.0m—
Capital spending—−£53.0m——————
Free cash flow—£0——————
Total assets£6.10bn£6.04bn£2.87bn£2.79bn£2.79bn£2.83bn£2.84bn£2.84bn
Cash and short-term investments£31.0m£20.0m£11.5m£3.5m£4.1m£3.2m£2.4m£2.4m
Debt£104.0m£9.0m£154.1m£151.7m£2.6m£2.4m£2.4m£1.29bn
Shareholders' equity£2.56bn£2.55bn£1.39bn£1.38bn£1.38bn£1.42bn£1.48bn£1.48bn

Financial ratios

Data as of 27 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2013FY2011
Gross margin89.6%85.7%88.9%100.0%100.0%100.0%—————
Operating margin79.5%51.6%46.5%113.7%63.6%87.4%—————
Net margin45.9%22.8%16.1%65.7%62.9%87.1%—————
Return on equity4.7%3.0%1.9%3.8%9.3%7.9%—————
Return on assets2.0%1.5%1.0%2.0%4.9%4.2%—————
Free cash flow yield0.1%———0.2%—0.1%—0.2%0.2%0.3%
Revenue growth42.5%7.0%98.1%-61.5%73.2%-376.6%—————
Earnings growth187.4%51.6%-51.5%-59.8%25.1%-257.1%—————
Current ratio6.67x0.02x0.63x0.75x0.73x1.78x—————
Debt to equity0.00x0.11x0.00x0.00x0.00x0.86x—————
Equity ratio42.3%49.3%50.4%51.7%52.6%52.4%—————
Interest coverage2.42x2.00x1.66x2.40x3.58x2.66x—————
R&D as a share of sales——0.0%0.0%0.0%0.0%-0.0%0.0%———
Buybacks as a share of market value-95.0%0.0%0.0%7.2%-3.0%-17.4%—————

Growth per year

Compound annual rate

3 years5 years10 years
Revenue44.6%15.0%15.2%
Operating income27.5%12.4%13.8%
Net income28.3%1.2%7.8%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin88.0%89.7%93.1%93.9%
Operating margin67.1%68.6%77.3%83.9%
Net margin36.4%35.0%47.4%53.8%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings21.430.150.826.315.619.1-26.711.18.317.4
Price to sales9.86.98.217.39.816.6-41.010.310.511.3

Dividends and splits

Per share, in the currency the company pays

Paid for 29 years. Last went ex-dividend on 15 Oct 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.0730.0910.0890.060.0650.0620.0210.026
  • 4-for-1 split · 12 Nov 2015

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.